Taysha Gene Therapies
TSHA
NASDAQ
IPO2020
about TSHA
Taysha Gene Therapies is a biotechnology company focused on developing advanced gene therapies to treat rare and life-threatening genetic diseases.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $4.04 | $4.83 | $3.98 | $867.49M | 80.26M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| -$0.09 | n/a | 667.70 | -1347.08% | -1353.58% | 0% |